John Jahangir Alam

This inventor holds 9 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Eip Pharma, LLC, Vertex Pharmaceuticals, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Jahangir Alam. Retrieved from https://idiyas.com/inventor/john-jahangir-alam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 9)

% Patents Active = 88.9

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 1.2

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Cambridge, MA (US) (2013 - 2020)
Boston, MA (US) (2022)

Company Filing History:

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2013-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734174 - Treatment of a selective population of patients having dementia with Lewy bodies (2026-09-15),

2. 11466008 - Co-crystals of neflamapimod (VX-745) (2022-10-11),

3. 10653695 - Pharmaceutical formulations of neflamapimod (2020-05-19),

4. 10420770 - Compositions and methods for treating dementia (2019-09-24),

5. 9579322 - Methods for treating neurologic disorders (2017-02-28),

6. 9427439 - Methods and compositions for recovery from stroke (2016-08-30),

7. 9427438 - Compositions and methods for treating Alzheimer's disease (2016-08-30),

8. 8697627 - Compositions and methods for treating alzheimer's disease (2014-04-15),

9. 8431615 - Dose forms (2013-04-30),

Title: John Jahangir Alam: Innovator in Pharmaceutical Formulations

Introduction

John Jahangir Alam is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work primarily focuses on innovative formulations and compounds that have the potential to improve therapeutic outcomes.

Latest Patents

Among his latest patents is the development of co-crystals of neflamapimod (VX-745). This patent describes co-crystal forms that include 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one (VX-745) and compositions that serve as inhibitors of various protein kinases. These co-crystals exhibit desirable characteristics for their intended use. Another notable patent involves pharmaceutical formulations of neflamapimod, which discloses oral compositions that provide suitable exposure for human administration while maintaining a desirable dissolution profile under standard storage conditions.

Career Highlights

John has worked with several reputable companies in the pharmaceutical industry, including Eip Pharma, LLC and Vertex Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, John has collaborated with notable professionals in the field, including Jeffrey Douglas Wilson and Hui-May Chu. These collaborations have further enhanced his research and development efforts.

Conclusion

John Jahangir Alam is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.